Is there an interaction between interleukin-10 and interleukin-22?

被引:0
|
作者
K Wolk
E Witte
U Reineke
K Witte
M Friedrich
W Sterry
K Asadullah
H-D Volk
R Sabat
机构
[1] University Hospital Charité,Interdisciplinary Group of Molecular Immunopathology, Dermatology Medical, Immunology
[2] Jerini AG,Department of Dermatology
[3] University Hospital Charité,Institute of Medical Immunology
[4] CRBA Dermatology,undefined
[5] Schering AG,undefined
[6] University Hospital Charité,undefined
来源
Genes & Immunity | 2005年 / 6卷
关键词
IL-26; IL-28; IL-29; IL-22RA2; IL-22BP; receptor binding site;
D O I
暂无
中图分类号
学科分类号
摘要
Interleukin(IL)-10 and IL-22 are structurally related cytokines. Their heterodimeric receptors consist of the cytokine-specific chains IL-10R1 and IL-22R1, respectively, and the common chain IL-10R2. This study focused on the question of whether IL-10 modulates IL-22 effects and vice versa. This question is important because IL-10 and IL-22 exert anti- and proinflammatory effects, respectively, and, as we show here, are simultaneously present in both systemic and local inflammation. The revealed lacking concomitance of IL-10R1 and IL-22R1 on identical cells excluded any possible interaction between IL-10 and IL-22 apart from the competition for IL-10R2. To study this competition, monocytes and hepatocytes were chosen. The dependence of the cytokine action on IL-10R2 was verified. Interestingly, no influence of IL-22 on IL-10 effects was observed. The same was true when IL-22 was used in complex with IL-22-binding protein. Similarly, no influence of IL-10 was found on IL-22 action. This missing competition seemed to be due to a lack of binding between IL-10R2 and the native cytokines in the absence of their corresponding R1 chain. However, IL-10R2 interacted with defined IL-10- and IL-22-derived peptides supporting the hypothesis that cytokine binding to its corresponding R1 chain creates a binding site on this cytokine for IL-10R2.
引用
收藏
页码:8 / 18
页数:10
相关论文
共 50 条
  • [41] Interleukin-10 and interleukin-10 receptor in human osteoarthritic and healthy chondrocytes
    Iannone, F
    De Bari, C
    Dell'Accio, F
    Covelli, M
    Cantatore, FP
    Patella, V
    Lo Bianco, G
    Lapadula, G
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2001, 19 (02) : 139 - 146
  • [42] Role of interleukin-10 and interleukin-10 receptor in systemic lupus erythematosus
    Hui Peng
    Wei Wang
    Mo Zhou
    Rui Li
    Hai-Feng Pan
    Dong-Qing Ye
    [J]. Clinical Rheumatology, 2013, 32 : 1255 - 1266
  • [43] Role of interleukin-10 and interleukin-10 receptor in systemic lupus erythematosus
    Peng, Hui
    Wang, Wei
    Zhou, Mo
    Li, Rui
    Pan, Hai-Feng
    Ye, Dong-Qing
    [J]. CLINICAL RHEUMATOLOGY, 2013, 32 (09) : 1255 - 1266
  • [44] Epithelial polarity is disrupted by interleukin-22
    Lebenheim, L.
    May, C.
    Munoz, M.
    Heimesaat, M. M.
    Siegmund, B.
    Schulzke, J. -D.
    Schumann, M.
    [J]. JOURNAL OF CROHNS & COLITIS, 2014, 8 : S15 - S15
  • [45] Interleukin-22 promotes tumor angiogenesis
    Nicholas J. Protopsaltis
    Wei Liang
    Eric Nudleman
    Napoleone Ferrara
    [J]. Angiogenesis, 2019, 22 : 311 - 323
  • [46] Targeting interleukin-22 for cancer therapy
    Markota, Anamarija
    Endres, Stefan
    Kobold, Sebastian
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (08) : 2012 - 2015
  • [47] The role of interleukin-22 in pityriasis rosea
    Al Mokadem, S.
    Ghonemy, S.
    Zidan, A.
    Abd El Aleem, G.
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2017, 42 (01) : 30 - 35
  • [48] Interleukin-22 and its crystal structure
    Pinto Nagem, Ronaldo Alves
    Ferreira Junior, Josii Ribamar
    Dumoutier, Laure
    Renauld, Jean-Christophe
    Polikarpov, Igor
    [J]. INTERLEUKINS, 2006, 74 : 77 - 103
  • [49] Lactobacillus delivery of bioactive interleukin-22
    Yin Lin
    Kasper Krogh-Andersen
    Lennart Hammarström
    Harold Marcotte
    [J]. Microbial Cell Factories, 16
  • [50] Interleukin-22 acts as a mitochondrial protector
    Hwang, Seonghwan
    Feng, Dechun
    Gao, Bin
    [J]. THERANOSTICS, 2020, 10 (17): : 7836 - 7840